Lee June Insider Trades

Insider Trading History

Track insider trading activity for Lee June. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tenaya Therapeutics
Tenaya Therapeutics TNYA
Director
Holding Value $87.1k 120,000 shares
Last Trade
May 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$96k 120,000 shares
$0.80
$0.73
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Director
Holding Value $13.5k 3,430 shares
Last Trade
Jan 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.93k 3,430 shares
$1.73
$3.95
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Director
Holding Value $0 0 shares
Last Trade
Jan 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.93k 3,430 shares
$1.73
$3.95
Tenaya Therapeutics
Tenaya Therapeutics TNYA
Director
Holding Value $78k 107,400 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.3k 107,400 shares
$0.44
$0.73
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Director
Holding Value $122k 30,870 shares
Last Trade
Jan 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 30,870 shares
$4.04
$3.95
Tenaya Therapeutics
Tenaya Therapeutics TNYA
Director
Holding Value $24.7k 34,000 shares
Last Trade
Oct 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.4k 34,000 shares
$2.04
$0.73
Tenaya Therapeutics
Tenaya Therapeutics TNYA
Director
Holding Value $21.4k 29,532 shares
Last Trade
Jun 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210k 29,532 shares
$7.12
$0.73
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Director
Holding Value $594k 150,437 shares
Last Trade
May 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$346k 150,437 shares
$2.30
$3.95
CinCor Pharma
CinCor Pharma CINC
Director
Holding Value $0 0 shares
Last Trade
Feb 24, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.39M 47,954 shares
$29.06
$29.06
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Director
Holding Value $79k 20,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.6k 20,000 shares
$3.08
$3.95
Tenaya Therapeutics
Tenaya Therapeutics TNYA
Director
Holding Value $28.8k 39,727 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$209k 39,727 shares
$5.26
$0.73
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Director
Holding Value $79k 20,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$79.4k 20,000 shares
$3.97
$3.95
CinCor Pharma
CinCor Pharma CINC
Director
Holding Value $1.39M 47,954 shares
Last Trade
Jan 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$29.06
Tenaya Therapeutics
Tenaya Therapeutics TNYA
Director
Holding Value $13.7k 18,937 shares
Last Trade
Nov 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$410k 18,937 shares
$21.65
$0.73
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Director
Holding Value $0 0 shares
Last Trade
Dec 08, 2020 Sale
No data
No data
$3.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up